Colorectal Carcinoma clinical trials

Explore recruiting colorectal carcinoma clinical trials.

Recruiting colorectal carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Colorectal Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, randomised, open label, multicentre study to evaluate efficacy and safety of an intraperitoneal α-emitting radionuclide therapy (Radspherin®) in patients with peritoneal carcinomatosis from colorectal carcinoma following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)

Netherlands, Norway, Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

A pilot study of the safety and tolerability of oral administration of PD L 506 and the subsequent diagnostic value of porphyrin concentration (coproporphyrin I / III, CP I / III) in urine in patients with the first occurrence of colorectal cancer and in healthy subjects.

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A study to test different doses of BI 765049 in people with advanced cancer of the colon, rectum, stomach, or pancreas

Spain, Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Impact of Biweekly and Triweekly Dosing Regimens on Progression-Free Survival in First-Line FOLFIRI Treatment of Metastatic Colorectal Cancer: A Non-Inferiority Study (FIR-DIR)

Hungary

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Open Label, Multicenter, Randomized Study, to Evaluate the Efficacy and Safety of Denikitug Monotherapy and Denikitug-based Combinations in Participants With Advanced Microsatellite Stable (MSS) Colorectal Cancer (CRC).

Spain, Italy, France

Therapeutic exploratory (Phase II) EU CTIS Study details

REPROGRAM-02 : Induction Regorafenib in combination with metronomic cyclophosphamide, capecitabine, and low-dose aspirin followed by chemotherapy in second line metastatic colorectal cancer carcinoma An open-label randomized phase II-III study

France

Phase II and Phase III (Integrated) EU CTIS Study details

Colorectal Carcinoma trials by city

Colorectal Carcinoma in Toronto Colorectal Carcinoma in Vancouver Colorectal Carcinoma in Montreal Colorectal Carcinoma in Calgary Colorectal Carcinoma in Edmonton Colorectal Carcinoma in Ottawa Colorectal Carcinoma in Winnipeg Colorectal Carcinoma in Quebec City Colorectal Carcinoma in Hamilton Colorectal Carcinoma in Kitchener Colorectal Carcinoma in London Colorectal Carcinoma in Halifax Colorectal Carcinoma in New York Colorectal Carcinoma in Los Angeles Colorectal Carcinoma in Chicago Colorectal Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease